Skip to main content
SpringerLink
Log in

In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates ofPseudomonas aeruginosa

  • Articles
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

Abstract

Minimal inhibitory concentrations of the monobactam carumonam (RO 17-2301) and twelve other antimicrobials were determined using agar dilution against 140 recent nonreplicate clinical isolates of Pseudomonas aeruginosa.The most active drugs were ciprofloxacin, amikacin, imipenem and ceftazidime, inhibiting 96, 91, 90 und 86 percent of the strains, respectively, at or below the susceptibility threshold. The monobactams carumonam and aztreonam were active against 78 and 65 percent of the strains, respectively. Tobramycin inhibited 68 percent of the strains, and gentamicin and netilmicin 50 and 21 percent, respectively. Analysis of correlation coefficients revealed a low correlation between imipenem and the other beta-lactams and a remarkably good correlation between the beta-lactams (excepting imipenem) and the aminoglycosides.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sherertz, R. J., Sarubbi, F. A.: A three-year study of nosocomial infections associated withPseudomonas aeruginosa. Journal of Clinical Microbiology 1983, 18: 160–164.

    PubMed  Google Scholar 

  2. Van der Auwera, P., Schuyteneer, F.: In-vitro susceptibility ofPseudomonas aeruginosa to old and new beta-lactam antibiotics and aminoglycosides. Journal of Antimicrobial Chemotherapy 1983, 11: 511–515.

    PubMed  Google Scholar 

  3. Sticht-Groh, V.: Tracing ofPseudomonas aeruginosa infection by the use of commercial antisera and pyocin production and the evaluation of the results on the basis of the chi-square test. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene (A) 1979, 244: 240–250.

    Google Scholar 

  4. Bergan, T.: Epidemiological typing ofPseudomonas aeruginosa. In: Brown, M. R. W. (ed.): Resistance ofPseudomonas aeruginosa. John Wiley and Sons, London 1975, p. 189–235.

    Google Scholar 

  5. Govan, J. R. W., Gillies, R. R.: Further studies in the pyocine typing ofPseudomonas pyocyanea. Journal of Medical Microbiology 1969, 2: 17–25.

    PubMed  Google Scholar 

  6. Govan, J. R. W.: Pyocin typing ofPseudomonas aeruginosa. In: Bergan, T., Norris, J. R. (ed.): Methods in microbiology. Volume 10. Academic Press, London, 1978, p. 61–91.

    Google Scholar 

  7. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Villanova, PA, NCCLS, 1985.

    Google Scholar 

  8. Barry, A. L., Jones, R. N., Thornsberry, C.: Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test. Antimicrobial Agents and Chemotherapy 1981, 20: 525–529.

    PubMed  Google Scholar 

  9. Brokopp, C. D., Gomez-Lus, R., Farmer III, J. J.: Serological typing ofPseudomonas aeruginosa: use of commercial antisera and live antigens. Journal of Clinical Microbiology 1977, 5: 640–649.

    PubMed  Google Scholar 

  10. Legakis, N. J., Aliferopoulou, M., Papavassiliou, J., Papapetropoulou, M.: Serotypes ofPseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility. Journal of Clinical Microbiology 1982, 16: 458–463.

    PubMed  Google Scholar 

  11. Chau, P. Y., Ling, J., Ng, W. S.: Cefoperazone against carbenicillin-resistant isolates ofPseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoylthienamycin. Journal of Antimicrobial Chemotherapy 1983, 12: 337–345.

    Google Scholar 

  12. Williams, R. J., Lindridge, M. A., Said, A. A., Livermore, D. M., Williams, J. D.: National survey of antibiotic resistance inPseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 1984, 14: 9–16.

    PubMed  Google Scholar 

  13. Righter, J.: In vitro activity of ciprofloxacin, azthreonam and ceftazidime againstSerratia marcescens andPseudomonas aeruginosa. European Journal of Clinical Microbiology 1984, 3: 368–369.

    Article  PubMed  Google Scholar 

  14. Wiedemann, B., Machka, K., Malottke, R.: Multicenter study of the sensivity ofPseudomonas aeruginosa to antimicrobial agents. European Journal of Clinical Microbiology 1985, 4: 229–230.

    Article  PubMed  Google Scholar 

  15. Ng, W. W. S., Chau, P. Y., Leung, Y. K., Livermore, D. M.: In vitro activities of RO 17-2301 and azthreonam compared with those of other new beta-lactam antibiotics against clinical isolates ofPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1985, 27: 872–873.

    PubMed  Google Scholar 

  16. Fernandes, C. J., Stevens, D. A., Ackermann, V. P.: Comparative antibacterial activities of new beta-lactam antibiotics againstPseudomonas aeruginosa. Chemotherapy 1985, 31: 292–296.

    PubMed  Google Scholar 

  17. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. Villanova, PA, NCCLS, 1984.

    Google Scholar 

  18. Livermore, D. M., Williams, R. J., Williams, J. D.: Invitro activity of MK0787 (N-formimidoyl thienamycin) againstPseudomonas aeruginosa and other gramnegative organisms and its stability to their betalactamases. Journal of Antimicrobial Chemotherapy 1981, 8: 355–362.

    PubMed  Google Scholar 

  19. Tausk, F., Evans, M. E., Patterson, L. S., Federspiel, C., Stratton, C. W.: Imipenem-induced resistance to antipseudomonal beta-lactams inPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1985, 28: 41–45.

    PubMed  Google Scholar 

  20. Yoshimura, F., Nikaido, H.: Diffusion of bcta-lactam antibiotics through the porin channels ofEscherichia coli K 12. Antimicrobial Agents and Chemotherapy 1985, 27: 84–92.

    PubMed  Google Scholar 

  21. Livermore, D. M., Williams, R. J., Williams, J. D.: Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone againstPseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 1981, 8: 323–331.

    PubMed  Google Scholar 

  22. Livermore, D. M.: Beta-lactamases ofPseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 1982, 10: 168–171.

    PubMed  Google Scholar 

  23. Forster, T. J.: Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria. Microbiological Reviews 1983, 47: 361–409.

    PubMed  Google Scholar 

  24. Rivera, M. J., Vitoria, M. A., Navarro, M., Robledano, L., Chocarro, P., Gomez Lus, R.: Hospital dissemination among gram-negative bacillus strains of an inc M plasmid encoding an AAC (3) and a TEM-1 betalactamase. Drugs under Experimental and Clinical Research 1984, 10: 789–795.

    Google Scholar 

  25. Jacoby, G. A., Matthew, M.: The distribution of beta-lactamase genes on plasmids found inPseudomonas. Plasmid 1979, 2: 41–47.

    Article  PubMed  Google Scholar 

  26. Goldstein, F. W., Gutmann, L., Williamson, R., Collatz, E., Acar, J. F.: In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain ofSerratia marcescens. Annales de Microbiologic (A) 1983, 134: 329–337.

    Google Scholar 

  27. Michael, P. R., Alford, R. H., McGee, Z. A.: Superior activity of N-formimidoyl thienamycin against gentamicin-resistantPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1981. 20: 702–704.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Medical Microbiology, University of Zurich, Gloriastraße 32, 8028, Zurich, Switzerland

    U. Vurma-Rapp & F. -H. Kayser

Authors
  1. U. Vurma-Rapp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. -H. Kayser
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vurma-Rapp, U., Kayser, F.H. In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates ofPseudomonas aeruginosa . Eur. J, Clin. Microbiol. 5, 292–296 (1986). https://doi.org/10.1007/BF02017784

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02017784

Keywords

Search

Navigation